Growth hormone secretagogues

   
   

What is disclosed are growth hormone secretagogues, and their uses, of the formula ##STR1## wherein R1 is C.sub.6 H.sub.5 CH.sub.2 OCH.sub.2 --, C.sub.6 H.sub.5 (CH.sub.2)3-- or indol-3-ylmethyl; Y is pyrrolidin-1-yl, 4-C.sub.1 -C.sub.6 alkylpiperidin-1-yl or NR2R2; R2 are each independently a C.sub.1 to C.sub.6 alkyl; R3 is 2-napthyl or phenyl para-substituted by W; W is H, F, CF.sub.3, C.sub.1 -C.sub.6 alkoxy or phenyl; and R4 is H or CH.sub.3, or a pharmaceutically acceptable salt or solvate thereof.

Che cosa è rilevato sono i secretagogues dell'ormone di sviluppo ed i loro usi, del ## del ## STR1 di formula in cui R1 è C.sub.6 H.sub.5 CH.sub.2 OCH.sub.2 --. C.sub.6 H.sub.5 (CH.sub.2)3 -- o indol-3-ylmethyl; Y è pyrrolidin-1-yl, 4-C.sub.1 - C.sub.6 alkylpiperidin-1-yl o NR2R2; R2 sono indipendentemente ciascuno un C.sub.1 ad alchile C.sub.6; R3 è 2-napthyl o fenile paragrafo-sostituito da W; Il W è H, F, CF.sub.3, C.sub.1 - C.sub.6 alcossi o fenilico; e R4 è H o CH.sub.3, o un sale o un solvate farmaceuticamente accettabile di ciò.

 
Web www.patentalert.com

< Compositions and methods for the therapy and diagnosis of ovarian cancer

< Catheter anchoring system

> Expanded stent and a method for producing same

> Bluntable needle assembly with open-ended blunting probe

~ 00147